Novel Therapeutics for Anthracycline Induced Cardiotoxicity

By rosaguerrero • May 9, 2022

Vuong JT, Stein-Merlob AF, Cheng RK, Yang EH. Novel Therapeutics for Anthracycline Induced Cardiotoxicity. Front Cardiovasc Med. 2022 Apr 22;9:863314. doi: 10.3389/fcvm.2022.863314. PMID: 35528842; PMCID: PMC9072636.

Tags: anthracyclines, cardio-oncology, Cardiology/Epi, cardiomyopathy, cardiotoxicity, heart failure, Publications

Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021

Sayed A, Abramov D, Fonarow GC, Mamas MA, Kobo O, Butler J, Fudim M. Reversals in the Decline of Heart Failure Mortality in the US,[...]

Early-Onset Hypertension and Sex-Specific Residual Risk for Cardiovascular Disease in Type 2 Diabetes

Ji H, Ebinger JE, Kwan AC, Reue K, Sullivan JC, Shyy J, Cheng S. Early-Onset Hypertension and Sex-Specific Residual Risk for Cardiovascular Disease in Type[...]

Weathering the Storm With Intercostal Blockade: Repurposing an Old Approach for a Novel Application

Krokhaleva Y, Vaseghi M. Weathering the Storm With Intercostal Blockade: Repurposing an Old Approach for a Novel Application. JACC Clin Electrophysiol. 2024 Apr;10(4):747-749. doi: 10.1016/j.jacep.2024.02.010. PMID:[...]